Standard
The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms. / Holmström, Morten Orebo; Hjortso, M. D.; Ahmad, S. M.; Met, O.; Martinenaite, E.; Riley, C.; Straten, P.; Svane, I. M.; Hasselbalch, H. C.; Andersen, Mads Hald.
I:
Leukemia, Bind 31, 2017, s. 495-498.
Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt
Harvard
Holmström, MO, Hjortso, MD, Ahmad, SM
, Met, O, Martinenaite, E, Riley, C, Straten, P
, Svane, IM, Hasselbalch, HC & Andersen, MH 2017, '
The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms',
Leukemia, bind 31, s. 495-498.
https://doi.org/10.1038/leu.2016.290APA
Holmström, M. O., Hjortso, M. D., Ahmad, S. M.
, Met, O., Martinenaite, E., Riley, C., Straten, P.
, Svane, I. M., Hasselbalch, H. C., & Andersen, M. H. (2017).
The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms.
Leukemia,
31, 495-498.
https://doi.org/10.1038/leu.2016.290Vancouver
Holmström MO, Hjortso MD, Ahmad SM
, Met O, Martinenaite E, Riley C o.a.
The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms.
Leukemia. 2017;31:495-498.
https://doi.org/10.1038/leu.2016.290Author
Holmström, Morten Orebo ; Hjortso, M. D. ; Ahmad, S. M. ; Met, O. ; Martinenaite, E. ; Riley, C. ; Straten, P. ; Svane, I. M. ; Hasselbalch, H. C. ; Andersen, Mads Hald. / The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms. I: Leukemia. 2017 ; Bind 31. s. 495-498.
Bibtex
@article{a5b8831d3f2b4c6da56c5fcabdde2070,
title = "The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms",
author = "Holmstr{\"o}m, {Morten Orebo} and Hjortso, {M. D.} and Ahmad, {S. M.} and O. Met and E. Martinenaite and C. Riley and P. Straten and Svane, {I. M.} and Hasselbalch, {H. C.} and Andersen, {Mads Hald}",
year = "2017",
doi = "10.1038/leu.2016.290",
language = "English",
volume = "31",
pages = "495--498",
journal = "Leukemia",
issn = "0887-6924",
publisher = "nature publishing group",
}
RIS
TY - JOUR
T1 - The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms
AU - Holmström, Morten Orebo
AU - Hjortso, M. D.
AU - Ahmad, S. M.
AU - Met, O.
AU - Martinenaite, E.
AU - Riley, C.
AU - Straten, P.
AU - Svane, I. M.
AU - Hasselbalch, H. C.
AU - Andersen, Mads Hald
PY - 2017
Y1 - 2017
U2 - 10.1038/leu.2016.290
DO - 10.1038/leu.2016.290
M3 - Letter
C2 - 27761006
VL - 31
SP - 495
EP - 498
JO - Leukemia
JF - Leukemia
SN - 0887-6924
ER -
